Response of patients at the different ends of treatment cycles
sCR(stringent
The median durations for the first ≥PR were 2 (range: 2–5 months) and 4 (range: 2–6 months) months in the ICd and Id groups, respectively. An improved response was observed as the patients received more treatment cycles (Figure Relationship between ORR and treatment cycles in ICd group and Id group. ORR: response of PR or better, objective response rate, including PR(partial response) VGPR (very good partial response), CR(complete response) and sCR(stringent complete response); Id: ixazomib+dexamethasone. ICd: ixazomib+cyclophosphamide+dexamethasone. 